Pharmacokinetic Interpretation of Applying Local Drug Delivery System for the Treatment of Deep Surgical Site Infection in the Spine
- PMID: 38258104
- PMCID: PMC10819048
- DOI: 10.3390/pharmaceutics16010094
Pharmacokinetic Interpretation of Applying Local Drug Delivery System for the Treatment of Deep Surgical Site Infection in the Spine
Abstract
Surgical site infections (SSIs) after spinal surgery present significant challenges, including poor antibiotic penetration and biofilm formation on implants, leading to frequent treatment failures. Polymethylmethacrylate (PMMA) is widely used for localized drug delivery in bone infections, yet quantifying individual drug release kinetics is often impractical. This retrospective study analyzed 23 cases of deep SSIs (DSSIs) following spinal surgery treated with antibiotic-loaded PMMA. A mathematical model estimated personalized drug release kinetics from PMMA, considering disease types, pathogens, and various antibiotics. The study found that vancomycin (VAN), ceftriaxone (CRO), and ceftazidime (CAZ) reached peak concentrations of 15.43%, 15.42%, and 15.41%, respectively, within the first two days, which was followed by a lag phase (4.91-4.92%) on days 2-3. On days 5-7, concentrations stabilized, with CRO at 3.22% and CAZ/VAN between 3.63% and 3.65%, averaging 75.4 µg/cm2. Key factors influencing release kinetics include solubility, diffusivity, porosity, tortuosity, and bead diameter. Notably, a patient with a low glomerular filtration rate (ASA IV) was successfully treated with a shortened 9-day intravenous VAN regimen, avoiding systemic complications. This study affirms the effectiveness of local drug delivery systems (DDS) in treating DSSIs and underscores the value of mathematical modeling in determining drug release kinetics. Further research is essential to optimize release rates and durations and to mitigate risks of burst release and tissue toxicity.
Keywords: antibiotics-loaded bone cement; drug delivery system; drug release kinetic; mathematical model; polymethylmehthacrylate (PMMA); surgical site infection; sustained release.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Effects of bead size and polymerization in PMMA bone cement on vancomycin release.Biomed Mater Eng. 2008;18(6):377-85. doi: 10.3233/BME-2008-0554. Biomed Mater Eng. 2008. PMID: 19197114
-
Antibiotic-Loaded Polymethylmethacrylate Beads and Spacers in Treatment of Orthopedic Infections and the Role of Biofilm Formation.Front Microbiol. 2019 Jul 25;10:1626. doi: 10.3389/fmicb.2019.01626. eCollection 2019. Front Microbiol. 2019. PMID: 31402901 Free PMC article. Review.
-
Determining potential of PMMA as a depot for rifampin to treat recalcitrant orthopaedic infections.Injury. 2017 Oct;48(10):2095-2100. doi: 10.1016/j.injury.2017.08.021. Epub 2017 Aug 16. Injury. 2017. PMID: 28842287
-
3D printed bioceramics for dual antibiotic delivery to treat implant-associated bone infection.Eur Cell Mater. 2015 Nov 4;30:232-47. doi: 10.22203/ecm.v030a16. Eur Cell Mater. 2015. PMID: 26535494 Free PMC article.
-
Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.Int J Med Sci. 2009 Sep 4;6(5):247-52. doi: 10.7150/ijms.6.247. Int J Med Sci. 2009. PMID: 19834590 Free PMC article. Review.
Cited by
-
Strategies and applications of antibacterial surface-modified biomaterials.Bioact Mater. 2025 Jul 9;53:114-140. doi: 10.1016/j.bioactmat.2025.07.009. eCollection 2025 Nov. Bioact Mater. 2025. PMID: 40688018 Free PMC article. Review.
References
-
- Takahashi H., Koda M., Funayama T., Noguchi H., Miura K., Mataki K., Shibao Y., Eto F., Kono M., Sato K., et al. Continuous local antibiotic perfusion for patients with surgical site infection after instrumented spinal surgery; a novel technique to retain the implants. J. Clin. Neurosci. 2021;93:70–74. doi: 10.1016/j.jocn.2021.09.001. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases